Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.

by Santosh Kumar, Kapil Mehta
Published 2012-01-01

Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer

by Kapil Mehta, Amy Han
Published 2011-02-01

Molecular oncology update: Breast cancer gene expression profiling

by Amit Verma, Jatinder Kaur, Kapil Mehta
Published 2015-07-01

Label-free recognition of drug resistance via impedimetric screening of breast cancer cells.

by Bilge Eker, Robert Meissner, Arnaud Bertsch, Kapil Mehta, Philippe Renaud
Published 2013-01-01

Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells.

by Anupam Kumar, Hui Gao, Jia Xu, James Reuben, Dihua Yu, Kapil Mehta
Published 2011-01-01

Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells.

by Anupam Kumar, Jia Xu, Samuel Brady, Hui Gao, Dihua Yu, James Reuben, Kapil Mehta
Published 2010-01-01

Metabolic Adaptations in Cancer Stem Cells

by Umesh Prasad Yadav, Tashvinder Singh, Pramit Kumar, Praveen Sharma, Harsimrat Kaur, Harsimrat Kaur, Sadhana Sharma, Sandeep Singh, Santosh Kumar, Kapil Mehta
Published 2020-06-01